Aim: To evaluate hybrid closed-loop with ultra-rapid insulin lispro (Lyumjev) in adults with type 1 diabetes (T1D).
Methods: In a double-blind, randomized, crossover study, 28 adults with T1D (mean±SD; age 44.5±10.7 years, HbA1c 7.1±0.9% [54±10mmol/mol]) underwent two 8-week periods comparing hybrid closed-loop with Lyumjev and hybrid closed-loop with standard insulin lispro in random order. CamAPS FX closed-loop system was used in both periods.
Results: In an intention-to-treat analysis, proportion of time sensor glucose was in target range (70 to 180mg/dL; primary endpoint) was greater with Lyumjev compared with standard insulin lispro (mean±SD; 78.7±9.8% vs. 76.2±9.6%; mean difference 2.5 percentage points [95%CI 0.8 to 4.2]; p=0.005). Mean sensor glucose was lower with Lyumjev compared with standard insulin lispro (142±14mg/dL vs. 146±16mg/dL; p=0.048). Proportion of time with sensor glucose <70mg/dL was similar between interventions (median[IQR] Lyumjev 2.3% [1.3-2.7%] vs. standard insulin lispro 2.1% [1.4-3.3%]; p=0.33). No severe hypoglycemia or ketoacidosis occurred.
Conclusions: The use of Lyumjev with CamAPS FX hybrid closed-loop increases time in range and reduces mean glucose with no difference in hypoglycemia compared with standard insulin lispro in adults with T1D.
Disclosure
M.Nwokolo: None. R.Lakshman: None. C.K.Boughton: Consultant; CamDiab Ltd., Speaker's Bureau; Ypsomed AG. J.Ware: Other Relationship; Ypsomed AG. J.M.Allen: Research Support; CamDiab Ltd. M.E.Wilinska: Consultant; CamDiab Ltd. H.Alwan: None. M.Evans: Advisory Panel; Zucara Therapeutics, Pila Pharma, Dexcom, Inc., Other Relationship; Novo Nordisk, AstraZeneca, Abbott Diabetes, Speaker's Bureau; Eli Lilly and Company. R.Hovorka: Advisory Panel; Ypsomed AG, Consultant; Abbott Diabetes, B.Braun, Speaker's Bureau; Eli Lilly and Company, Stock/Shareholder; CamDiab Ltd.
Funding
National Institute for Health and Care Research; Cambridge Biomedical Research Centre (BRC-1215-20014)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.